$KRO
KRONOS WORLDWIDE INC

2021 Q1 Form 10-Q Financial Statement

#000156459021024079 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $465.0M $421.0M
YoY Change 10.45% -3.55%
Cost Of Revenue $369.3M $332.9M
YoY Change 10.93% 1.74%
Gross Profit $95.70M $88.10M
YoY Change 8.63% -19.4%
Gross Profit Margin 20.58% 20.93%
Selling, General & Admin $58.00M $53.50M
YoY Change 8.41% -7.28%
% of Gross Profit 60.61% 60.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.70M $14.90M
YoY Change -14.77% 40.57%
% of Gross Profit 13.27% 16.91%
Operating Expenses $58.00M $53.50M
YoY Change 8.41% -7.28%
Operating Profit $34.00M $43.50M
YoY Change -21.84% -11.22%
Interest Expense $5.000M $7.300M
YoY Change -31.51% 52.08%
% of Operating Profit 14.71% 16.78%
Other Income/Expense, Net -$4.300M -$4.700M
YoY Change -8.51% 23.68%
Pretax Income $25.60M $35.40M
YoY Change -27.68% -17.87%
Income Tax $6.000M $8.400M
% Of Pretax Income 23.44% 23.73%
Net Earnings $19.60M $27.00M
YoY Change -27.41% -10.89%
Net Earnings / Revenue 4.22% 6.41%
Basic Earnings Per Share $0.17
Diluted Earnings Per Share $0.17 $233.6K
COMMON SHARES
Basic Shares Outstanding 115.5M 115.7M
Diluted Shares Outstanding 115.5M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $373.6M $341.5M
YoY Change 9.4% 0.59%
Cash & Equivalents $379.9M $342.9M
Short-Term Investments
Other Short-Term Assets $15.30M $12.10M
YoY Change 26.45% -12.32%
Inventory $473.0M $479.4M
Prepaid Expenses
Receivables $312.7M $305.3M
Other Receivables $25.60M $25.10M
Total Short-Term Assets $1.200B $1.163B
YoY Change 3.16% -3.3%
LONG-TERM ASSETS
Property, Plant & Equipment $531.7M $486.0M
YoY Change 9.4% 0.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $109.7M $94.20M
YoY Change 16.45% 9.41%
Other Assets $155.0M $131.2M
YoY Change 18.14% 3100.0%
Total Long-Term Assets $796.4M $711.4M
YoY Change 11.95% -1.74%
TOTAL ASSETS
Total Short-Term Assets $1.200B $1.163B
Total Long-Term Assets $796.4M $711.4M
Total Assets $1.997B $1.875B
YoY Change 6.5% -2.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $158.5M $111.2M
YoY Change 42.54% -0.54%
Accrued Expenses $51.20M $49.10M
YoY Change 4.28% -14.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $700.0K $1.400M
YoY Change -50.0% -6.67%
Total Short-Term Liabilities $255.2M $231.2M
YoY Change 10.38% -4.19%
LONG-TERM LIABILITIES
Long-Term Debt $465.9M $436.3M
YoY Change 6.78% -2.13%
Other Long-Term Liabilities $26.50M $406.0M
YoY Change -93.47% 10.63%
Total Long-Term Liabilities $492.4M $842.3M
YoY Change -41.54% 88.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $255.2M $231.2M
Total Long-Term Liabilities $492.4M $842.3M
Total Liabilities $1.196B $1.093B
YoY Change 9.45% 1.55%
SHAREHOLDERS EQUITY
Retained Earnings -$126.3M
YoY Change
Common Stock $1.397B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.000M
YoY Change
Treasury Stock Shares
Shareholders Equity $800.9M $782.3M
YoY Change
Total Liabilities & Shareholders Equity $1.997B $1.875B
YoY Change 6.5% -2.71%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $19.60M $27.00M
YoY Change -27.41% -10.89%
Depreciation, Depletion And Amortization $12.70M $14.90M
YoY Change -14.77% 40.57%
Cash From Operating Activities $56.70M -$9.800M
YoY Change -678.57% -240.0%
INVESTING ACTIVITIES
Capital Expenditures $10.80M $15.30M
YoY Change -29.41% -4.38%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.500M
YoY Change -100.0% -200.0%
Cash From Investing Activities -$10.80M -$13.80M
YoY Change -21.74% -21.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.000M
YoY Change
Debt Paid & Issued, Net $200.0K $100.0K
YoY Change 100.0% 0.0%
Cash From Financing Activities -21.00M -21.90M
YoY Change -4.11% 4.29%
NET CHANGE
Cash From Operating Activities 56.70M -9.800M
Cash From Investing Activities -10.80M -13.80M
Cash From Financing Activities -21.00M -21.90M
Net Change In Cash 35.70M -45.50M
YoY Change -178.46% 44.44%
FREE CASH FLOW
Cash From Operating Activities $56.70M -$9.800M
Capital Expenditures $10.80M $15.30M
Free Cash Flow $45.90M -$25.10M
YoY Change -282.87% 178.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
CY2021Q1 us-gaap Gross Profit
GrossProfit
95700000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
100000
CY2020Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
1500000
CY2021Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
800000
CY2021Q1 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
4300000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39000000.0
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5600000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12000000.0
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25200000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
816100000
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20800000
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000000.0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
782300000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
796500000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
19600000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5600000
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20800000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
27000000.0
CY2021Q1 us-gaap Profit Loss
ProfitLoss
19600000
CY2020Q1 us-gaap Depreciation
Depreciation
14900000
CY2021Q1 us-gaap Depreciation
Depreciation
12700000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1600000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1700000
CY2021Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
3700000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-900000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
200000
CY2020Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
3000000.0
CY2020Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1500000
CY2021Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
800000
CY2020Q1 kro Equity Method Investment Distributions From Contributions To Net
EquityMethodInvestmentDistributionsFromContributionsToNet
-2200000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1100000
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
38700000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3300000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3600000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30500000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9400000
CY2020Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
1500000
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-800000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9800000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15300000
CY2020Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
1500000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20800000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20800000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000.0
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21900000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21000000.0
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-45500000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24900000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3900000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000000.0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
392300000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
362000000.0
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342900000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
8500000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-100000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2300000
CY2020Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
3500000
CY2021Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
2700000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
323000000.0
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
338300000
CY2020Q4 us-gaap Inventory Net
InventoryNet
519000000.0
CY2021Q1 us-gaap Inventory Net
InventoryNet
473000000.0
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2200000
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
3300000
CY2020Q4 kro Equity Securities Fv Ni Accumulated Gross Unrealized Loss
EquitySecuritiesFvNiAccumulatedGrossUnrealizedLoss
1100000
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3000000.0
CY2021Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
3300000
CY2021Q1 kro Equity Securities Fv Ni Accumulated Gross Unrealized Loss
EquitySecuritiesFvNiAccumulatedGrossUnrealizedLoss
300000
CY2020Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
1700000
CY2021Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
1600000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
487400000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
466600000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
700000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
700000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
486700000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
465900000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
243800000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
238000000.0
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
111000000.0
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27800000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
29100000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6700000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6300000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
41300000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28300000
CY2020Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
400000
CY2020Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8700000
CY2021Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8800000
CY2020Q4 kro Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
6200000
CY2021Q1 kro Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
5800000
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
11800000
CY2021Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
11900000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26700000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26500000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
421000000.0
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
465000000.0
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
421000000.0
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
465000000.0
CY2021Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
17000000
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
900000
CY2021Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-500000
CY2020Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
300000
CY2020Q1 kro Incremental Tax Expense Benefit On Equity In Earnings
IncrementalTaxExpenseBenefitOnEquityInEarnings
-1300000
CY2021Q1 kro Incremental Tax Expense Benefit On Equity In Earnings
IncrementalTaxExpenseBenefitOnEquityInEarnings
-700000
CY2020Q1 kro Income Tax Reconciliation Global Intangible Low Tax Income Net
IncomeTaxReconciliationGlobalIntangibleLowTaxIncomeNet
1200000
CY2021Q1 kro Income Tax Reconciliation Global Intangible Low Tax Income Net
IncomeTaxReconciliationGlobalIntangibleLowTaxIncomeNet
500000
CY2020Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-500000
CY2021Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
500000
CY2021Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
100000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8400000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000000.0
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8400000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000000.0
CY2020Q1 kro Comprehensive Income Loss Tax
ComprehensiveIncomeLossTax
9800000
CY2021Q1 kro Comprehensive Income Loss Tax
ComprehensiveIncomeLossTax
7600000
CY2020Q1 kro Tax Cuts And Jobs Act Of2017 Effective Income Tax Rate Reconciliation Deduction Of Interest Income
TaxCutsAndJobsActOf2017EffectiveIncomeTaxRateReconciliationDeductionOfInterestIncome
0.30
CY2020Q1 kro Coronavirus Aid Relief And Economic Security Act Effective Income Tax Rate Reconciliation Deduction Of Interest Income
CoronavirusAidReliefAndEconomicSecurityActEffectiveIncomeTaxRateReconciliationDeductionOfInterestIncome
0.50
CY2020Q1 kro Cash Tax Benefit Due To Reversal Of Valuation Allowance
CashTaxBenefitDueToReversalOfValuationAllowance
500000
CY2021Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
1100000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
362000000.0
CY2020Q4 kro Cash Cash Equivalents And Restricted Cash Fair Value Disclosure
CashCashEquivalentsAndRestrictedCashFairValueDisclosure
362000000.0
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
379900000
CY2021Q1 kro Cash Cash Equivalents And Restricted Cash Fair Value Disclosure
CashCashEquivalentsAndRestrictedCashFairValueDisclosure
379900000
CY2020Q4 us-gaap Senior Notes
SeniorNotes
485700000
CY2020Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
499900000
CY2021Q1 us-gaap Senior Notes
SeniorNotes
465000000.0
CY2021Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
478100000

Files In Submission

Name View Source Status
0001564590-21-024079-index-headers.html Edgar Link pending
0001564590-21-024079-index.html Edgar Link pending
0001564590-21-024079.txt Edgar Link pending
0001564590-21-024079-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kro-10q_20210331.htm Edgar Link pending
kro-10q_20210331_htm.xml Edgar Link completed
kro-20210331.xsd Edgar Link pending
kro-20210331_cal.xml Edgar Link unprocessable
kro-20210331_def.xml Edgar Link unprocessable
kro-20210331_lab.xml Edgar Link unprocessable
kro-20210331_pre.xml Edgar Link unprocessable
kro-ex101_450.htm Edgar Link pending
kro-ex102_449.htm Edgar Link pending
kro-ex311_7.htm Edgar Link pending
kro-ex312_6.htm Edgar Link pending
kro-ex321_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending